CFAM
Center For Asset Management’s Eli Lilly LLY Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $502K | Sell |
649
-1
| -0.2% | -$774 | 0.31% | 68 |
|
|
2025
Q1 | $537K | Buy |
650
+1
| +0.2% | +$826 | 0.33% | 67 |
|
|
2024
Q4 | $501K | Buy |
649
+1
| +0.2% | +$772 | 0.32% | 65 |
|
|
2024
Q3 | $574K | Buy |
648
+1
| +0.2% | +$886 | 0.34% | 69 |
|
|
2024
Q2 | $586K | Buy |
647
+1
| +0.2% | +$906 | 0.39% | 58 |
|
|
2024
Q1 | $503K | Buy |
646
+1
| +0.2% | +$778 | 0.41% | 57 |
|
|
2023
Q4 | $376K | Sell |
645
-17
| -3% | -$9.91K | 0.34% | 68 |
|
|
2023
Q3 | $356K | Buy |
662
+1
| +0.2% | +$537 | 0.36% | 71 |
|
|
2023
Q2 | $310K | Buy |
661
+78
| +13% | +$36.6K | 0.29% | 78 |
|
|
2023
Q1 | $200K | Buy |
583
+2
| +0.3% | +$686 | 0.2% | 102 |
|
|
2022
Q4 | $212K | Sell |
581
-302
| -34% | -$110K | 0.2% | 106 |
|
|
2022
Q3 | $286K | Sell |
883
-1
| -0.1% | -$324 | 0.28% | 90 |
|
|
2022
Q2 | $287K | Sell |
884
-430
| -33% | -$140K | 0.27% | 87 |
|
|
2022
Q1 | $376K | Buy |
1,314
+84
| +7% | +$24K | 0.29% | 68 |
|
|
2021
Q4 | $340K | Buy |
1,230
+222
| +22% | +$61.4K | 0.25% | 75 |
|
|
2021
Q3 | $233K | Sell |
1,008
-20
| -2% | -$4.62K | 0.2% | 87 |
|
|
2021
Q2 | $236K | Sell |
1,028
-278
| -21% | -$63.8K | 0.2% | 87 |
|
|
2021
Q1 | $244K | Sell |
1,306
-566
| -30% | -$106K | 0.23% | 76 |
|
|
2020
Q4 | $316K | Buy |
+1,872
| New | +$316K | 0.32% | 55 |
|